CDXC: Chromadex Corp Company Profile & Statistics

About

ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. ChromaDex's core business strategy is to use the intellectual property harnessed by its expertise in the area of natural products and in the creation of reference materials to the industry as the basis for providing new and alternative, `green`, mass marketable products to its customers. The Company's main priority is to create industry-accepted information, and to provide products and services to every layer of the functional food, pharmaceutical, personal care and dietary supplement markets. The company markets and sells its products in the United States and Canada. It offers its products through distributors in Europe, South America, Korea, India, Japan, Australia, New Zealand, China, Indonesia, Malaysia, Singapore, Thailand, and Mexico.

Info & Links

CEO

Robert Fried

Headquarters

10900 Wilshire Blvd. Suite 600
Los Angeles, CA 90024, UNITED STATES

Auditor

Marcum LLP

Share holders

Employees

106

Chromadex Corp Statistics

Valuation Measures

Market Capitalization²

406.72M

Enterprise Value

374.34M

Enterprise Value/EBITDA(ttm)

290.64

Price to Earnings Ratio(ttm)

541.00

Price to Sales(ttm)

4.51

Price to Book(mrq)

12.02

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

61.37%

Operating Margin(ttm)

1.62%

Profit Margin(ttm)

1.40%

Return on Equity(ttm)

4.85%

Return on Invested Capital(ttm)

4.12%

Return on Assets(ttm)

2.70%

Income Statement

Revenue(ttm)

91.67M

Revenue Per Share(ttm)

1.20

Gross Profit(ttm)

56.33M

EBITDA(ttm)³

1.29M

Net Income Available to Common(ttm)

1.49M

Diluted EPS(ttm)

0.01

Share Statistics

Beta (5Y Monthly)

2.16

52-Week Change

280.36%

S&P 500 52-Week Change

24.82%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

76.38M

Dividend Yield

0.00%

Float⁴

69.02M

% Held by Insiders

9.64%

% Held by Institutions

15.41%

Balance Sheet

Total Cash(mrq)

32.40M

Total Cash Per Share(mrq)

0.42

Total Debt(mrq)

14.00K

Total Debt/Equity(mrq)

0.04%

Current Ratio(mrq)

2.95%

Quick Ratio(mrq)

2.35%

Book Value Per Share(mrq)

0.45

Cash Flow

Operating Cash Flow Per Share(ytd)

0.05

Free Cash Flow(ytd)

3.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CDXC

Chromadex Corp

Chromadex Corp Profile